OTC · Healthcare
Earth Science Tech, Inc. (ETST)
As-reported financials and recent SEC filings for Earth Science Tech, Inc., latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$35.7M
Net income
$3.6M
Net margin
10.2%
Diluted EPS
$0.01
ROE
51.6%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $35.7M | $33.1M | $12.0M | $48,537 | $14,123 |
| Gross profit | $25.5M | $24.3M | $7.8M | $22,060 | $-8,516 |
| Operating income | — | — | $892,349 | $-936,683 | $-226,706 |
| Net income | $3.6M | $3.3M | $812,139 | $-365,405 | $3.2M |
| Diluted EPS | $0.01 | $0.01 | $0.00 | $-0.00 | — |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
PRE 14A2026-07-02
View on EDGAR →SCHEDULE 13G2026-06-22
View on EDGAR →8-K2026-06-18
View on EDGAR →10-K2026-06-18
View on EDGAR →8-K2026-06-10
View on EDGAR →8-K2026-04-17
View on EDGAR →8-K2026-03-24
View on EDGAR →8-K2026-03-13
View on EDGAR →Largest Healthcare peers
Go deeper on ETST
Search Earth Science Tech, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.